| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 4.76× | 4.76× | 4.83× | 4.14× | 4.15× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.30× | 0.30× | 0.29× | 0.33× | 0.34× | ||
| 0.23× | 0.23× | −1.12× | −2.26× | −2.95× | ||
| 0.09× | 0.09× | −0.40× | −0.99× | −1.58× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 4.15 | 4.14 | 4.83 | 4.76 | 4.76 | |
| Asset Turnover | 0.34 | 0.33 | 0.29 | 0.30 | 0.30 | |
| Cash Conversion (CFO/Net Income) | -2.95 | -2.26 | -1.12 | 0.23 | 0.23 | |
| CFO/EBITDA | -1.58 | -0.99 | -0.40 | 0.09 | 0.09 |